| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 5 | 2021 | 253 | 1.750 |
Why?
|
| Thrombolytic Therapy | 3 | 2021 | 233 | 1.120 |
Why?
|
| Peripheral Arterial Disease | 4 | 2021 | 83 | 1.040 |
Why?
|
| Cardiac Catheterization | 5 | 2020 | 419 | 0.770 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2021 | 181 | 0.760 |
Why?
|
| Device Removal | 2 | 2020 | 100 | 0.750 |
Why?
|
| Lower Extremity | 5 | 2020 | 153 | 0.740 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2020 | 63 | 0.740 |
Why?
|
| Vena Cava Filters | 1 | 2020 | 18 | 0.710 |
Why?
|
| Foreign-Body Migration | 1 | 2020 | 38 | 0.710 |
Why?
|
| Hypertension | 5 | 2023 | 1535 | 0.700 |
Why?
|
| Vascular Calcification | 2 | 2020 | 131 | 0.670 |
Why?
|
| Contrast Media | 9 | 2022 | 595 | 0.650 |
Why?
|
| Hospital Rapid Response Team | 1 | 2018 | 9 | 0.630 |
Why?
|
| Heart Diseases | 3 | 2018 | 276 | 0.620 |
Why?
|
| Angioplasty | 3 | 2017 | 118 | 0.600 |
Why?
|
| Health Care Costs | 1 | 2020 | 346 | 0.580 |
Why?
|
| Catheters | 2 | 2021 | 39 | 0.570 |
Why?
|
| Aortography | 1 | 2017 | 72 | 0.560 |
Why?
|
| Computed Tomography Angiography | 3 | 2020 | 424 | 0.550 |
Why?
|
| Aorta, Abdominal | 1 | 2017 | 97 | 0.540 |
Why?
|
| Blood Pressure | 4 | 2014 | 1451 | 0.520 |
Why?
|
| Intermittent Claudication | 2 | 2012 | 31 | 0.500 |
Why?
|
| Femoral Artery | 2 | 2012 | 139 | 0.480 |
Why?
|
| Kidney | 3 | 2023 | 945 | 0.480 |
Why?
|
| Sympathectomy | 1 | 2014 | 24 | 0.470 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2018 | 504 | 0.450 |
Why?
|
| Myocardial Reperfusion | 1 | 2013 | 32 | 0.440 |
Why?
|
| Fibrinolytic Agents | 2 | 2021 | 377 | 0.430 |
Why?
|
| Thrombectomy | 3 | 2022 | 238 | 0.420 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2013 | 61 | 0.410 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2012 | 50 | 0.400 |
Why?
|
| Ischemia | 2 | 2016 | 229 | 0.400 |
Why?
|
| Stents | 6 | 2022 | 657 | 0.390 |
Why?
|
| Endocarditis, Bacterial | 1 | 2011 | 32 | 0.390 |
Why?
|
| Constriction, Pathologic | 6 | 2021 | 236 | 0.380 |
Why?
|
| Prosthesis-Related Infections | 1 | 2011 | 70 | 0.370 |
Why?
|
| Leg | 1 | 2012 | 191 | 0.370 |
Why?
|
| Humans | 36 | 2023 | 68618 | 0.350 |
Why?
|
| Catheterization | 2 | 2010 | 209 | 0.350 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2020 | 102 | 0.330 |
Why?
|
| Myocardial Infarction | 2 | 2013 | 807 | 0.320 |
Why?
|
| Treatment Outcome | 7 | 2021 | 7029 | 0.310 |
Why?
|
| Defibrillators, Implantable | 1 | 2011 | 329 | 0.300 |
Why?
|
| Hypertension, Pulmonary | 2 | 2020 | 232 | 0.290 |
Why?
|
| Patient Care Team | 2 | 2020 | 311 | 0.290 |
Why?
|
| Risk Assessment | 6 | 2020 | 2007 | 0.270 |
Why?
|
| Reproducibility of Results | 7 | 2021 | 2077 | 0.270 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2017 | 373 | 0.250 |
Why?
|
| Acute Kidney Injury | 2 | 2018 | 232 | 0.250 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2019 | 134 | 0.250 |
Why?
|
| Blood Flow Velocity | 2 | 2017 | 172 | 0.240 |
Why?
|
| Anticoagulants | 3 | 2020 | 356 | 0.240 |
Why?
|
| Male | 23 | 2023 | 37321 | 0.230 |
Why?
|
| Hospitalization | 3 | 2022 | 978 | 0.230 |
Why?
|
| Middle Aged | 18 | 2023 | 21147 | 0.220 |
Why?
|
| Aged | 14 | 2020 | 14862 | 0.220 |
Why?
|
| Denervation | 1 | 2023 | 23 | 0.220 |
Why?
|
| Triiodobenzoic Acids | 3 | 2017 | 28 | 0.220 |
Why?
|
| Antihypertensive Agents | 3 | 2023 | 498 | 0.210 |
Why?
|
| Time Factors | 5 | 2020 | 4655 | 0.210 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 119 | 0.200 |
Why?
|
| Female | 21 | 2023 | 38074 | 0.190 |
Why?
|
| Equipment Design | 3 | 2012 | 500 | 0.190 |
Why?
|
| Prospective Studies | 6 | 2020 | 3705 | 0.190 |
Why?
|
| Coronary Vessels | 2 | 2013 | 313 | 0.180 |
Why?
|
| Decision Trees | 1 | 2020 | 74 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 2324 | 0.180 |
Why?
|
| Models, Economic | 1 | 2020 | 69 | 0.180 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2020 | 106 | 0.170 |
Why?
|
| Pelvis | 1 | 2019 | 38 | 0.170 |
Why?
|
| Markov Chains | 1 | 2020 | 133 | 0.170 |
Why?
|
| Cost Savings | 1 | 2020 | 110 | 0.170 |
Why?
|
| Aftercare | 1 | 2020 | 114 | 0.170 |
Why?
|
| Abdomen | 1 | 2019 | 80 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor D | 1 | 2019 | 10 | 0.170 |
Why?
|
| Acute Disease | 1 | 2021 | 658 | 0.170 |
Why?
|
| Regional Blood Flow | 2 | 2017 | 168 | 0.160 |
Why?
|
| Risk Factors | 6 | 2021 | 5731 | 0.160 |
Why?
|
| Observer Variation | 2 | 2017 | 330 | 0.160 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 123 | 0.160 |
Why?
|
| Prosthesis Design | 1 | 2020 | 301 | 0.160 |
Why?
|
| Radiography, Interventional | 1 | 2018 | 49 | 0.160 |
Why?
|
| Iohexol | 1 | 2018 | 82 | 0.160 |
Why?
|
| Decision Support Techniques | 1 | 2020 | 191 | 0.160 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 323 | 0.150 |
Why?
|
| Group Processes | 1 | 2018 | 42 | 0.150 |
Why?
|
| Emergency Treatment | 1 | 2018 | 52 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 504 | 0.150 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 546 | 0.150 |
Why?
|
| Cerebrovascular Disorders | 1 | 2018 | 182 | 0.150 |
Why?
|
| Hospital Administration | 1 | 2017 | 43 | 0.150 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 1753 | 0.150 |
Why?
|
| Renal Insufficiency | 1 | 2018 | 121 | 0.150 |
Why?
|
| Patient Comfort | 1 | 2017 | 2 | 0.140 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 1465 | 0.140 |
Why?
|
| Cardiovascular System | 1 | 2017 | 85 | 0.140 |
Why?
|
| Iopamidol | 1 | 2017 | 37 | 0.140 |
Why?
|
| Registries | 1 | 2020 | 733 | 0.140 |
Why?
|
| Decision Making | 1 | 2020 | 410 | 0.140 |
Why?
|
| Blood Pressure Determination | 2 | 2014 | 152 | 0.140 |
Why?
|
| Vascular Diseases | 1 | 2017 | 94 | 0.140 |
Why?
|
| Angiography | 1 | 2017 | 194 | 0.130 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2016 | 73 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1851 | 0.120 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2016 | 92 | 0.120 |
Why?
|
| Ambulatory Care | 2 | 2020 | 340 | 0.120 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2011 | 100 | 0.110 |
Why?
|
| Parasympathetic Nervous System | 1 | 2013 | 14 | 0.110 |
Why?
|
| Algorithms | 2 | 2016 | 1196 | 0.110 |
Why?
|
| Sympathetic Nervous System | 1 | 2013 | 81 | 0.110 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 4848 | 0.110 |
Why?
|
| Proportional Hazards Models | 2 | 2012 | 792 | 0.110 |
Why?
|
| Ablation Techniques | 1 | 2013 | 33 | 0.110 |
Why?
|
| Coronary Circulation | 1 | 2013 | 136 | 0.110 |
Why?
|
| Hemodynamics | 2 | 2019 | 705 | 0.100 |
Why?
|
| Embolism | 1 | 2012 | 45 | 0.100 |
Why?
|
| Heart Failure | 2 | 2019 | 1180 | 0.100 |
Why?
|
| Retrospective Studies | 5 | 2021 | 7277 | 0.100 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2013 | 116 | 0.100 |
Why?
|
| Limb Salvage | 1 | 2012 | 39 | 0.100 |
Why?
|
| Haemophilus influenzae | 1 | 2011 | 16 | 0.100 |
Why?
|
| Quality of Life | 1 | 2020 | 1515 | 0.100 |
Why?
|
| Suction | 1 | 2011 | 33 | 0.100 |
Why?
|
| Radial Artery | 1 | 2012 | 43 | 0.100 |
Why?
|
| Lipids | 1 | 2013 | 298 | 0.100 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2012 | 178 | 0.090 |
Why?
|
| Vascular Patency | 1 | 2011 | 122 | 0.090 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2010 | 7 | 0.090 |
Why?
|
| Heart Atria | 1 | 2011 | 206 | 0.090 |
Why?
|
| United States | 4 | 2018 | 7367 | 0.090 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2010 | 38 | 0.090 |
Why?
|
| Embolectomy | 1 | 2010 | 5 | 0.090 |
Why?
|
| Angioplasty, Balloon | 1 | 2011 | 110 | 0.090 |
Why?
|
| Pulmonary Veins | 1 | 2010 | 56 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 2800 | 0.090 |
Why?
|
| Patient Safety | 1 | 2012 | 202 | 0.090 |
Why?
|
| Stroke | 1 | 2022 | 2163 | 0.080 |
Why?
|
| Radiography | 1 | 2010 | 572 | 0.080 |
Why?
|
| Catheter Ablation | 1 | 2010 | 229 | 0.080 |
Why?
|
| Osmolar Concentration | 2 | 2017 | 134 | 0.080 |
Why?
|
| Atrial Fibrillation | 1 | 2010 | 249 | 0.070 |
Why?
|
| Coronary Angiography | 3 | 2022 | 866 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2010 | 951 | 0.070 |
Why?
|
| Coronary Artery Disease | 1 | 2013 | 696 | 0.070 |
Why?
|
| Adult | 7 | 2020 | 21403 | 0.070 |
Why?
|
| Vascular Surgical Procedures | 2 | 2023 | 168 | 0.070 |
Why?
|
| Ethanol | 1 | 2013 | 893 | 0.070 |
Why?
|
| Signal-To-Noise Ratio | 2 | 2016 | 93 | 0.070 |
Why?
|
| Databases, Factual | 2 | 2018 | 622 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 1026 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1615 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2023 | 249 | 0.050 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 189 | 0.050 |
Why?
|
| Comorbidity | 2 | 2017 | 1426 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 50 | 0.050 |
Why?
|
| Lymphangiogenesis | 1 | 2019 | 10 | 0.040 |
Why?
|
| Respiration | 1 | 2019 | 91 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 115 | 0.040 |
Why?
|
| Artifacts | 1 | 2019 | 125 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2019 | 169 | 0.040 |
Why?
|
| Endovascular Procedures | 1 | 2023 | 366 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2020 | 453 | 0.040 |
Why?
|
| Models, Econometric | 1 | 2017 | 26 | 0.040 |
Why?
|
| Budgets | 1 | 2017 | 12 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2020 | 383 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2018 | 174 | 0.040 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 124 | 0.040 |
Why?
|
| Echocardiography | 1 | 2020 | 515 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 193 | 0.040 |
Why?
|
| Injections, Intra-Arterial | 1 | 2017 | 30 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2019 | 586 | 0.030 |
Why?
|
| Risk | 1 | 2017 | 563 | 0.030 |
Why?
|
| Inpatients | 1 | 2017 | 208 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2017 | 252 | 0.030 |
Why?
|
| Disease Progression | 1 | 2019 | 1038 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 772 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 2016 | 208 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2019 | 1330 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2020 | 2358 | 0.030 |
Why?
|
| Prognosis | 1 | 2019 | 2093 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 448 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1593 | 0.030 |
Why?
|
| Incidence | 1 | 2017 | 1603 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2013 | 31 | 0.030 |
Why?
|
| Angina Pectoris | 1 | 2013 | 61 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2013 | 216 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 1745 | 0.030 |
Why?
|
| Adenosine | 1 | 2013 | 165 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 1738 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2013 | 219 | 0.030 |
Why?
|
| Community Health Services | 1 | 2013 | 141 | 0.030 |
Why?
|
| Hirudins | 1 | 2012 | 32 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2013 | 172 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2012 | 80 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2012 | 65 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 2223 | 0.020 |
Why?
|
| Drug Utilization | 1 | 2012 | 119 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 10 | 0.020 |
Why?
|
| Massachusetts | 1 | 2011 | 28 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2011 | 25 | 0.020 |
Why?
|
| Hospital Mortality | 1 | 2013 | 384 | 0.020 |
Why?
|
| Retreatment | 1 | 2011 | 59 | 0.020 |
Why?
|
| Heparin | 1 | 2012 | 205 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2012 | 127 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2012 | 152 | 0.020 |
Why?
|
| Coronary Stenosis | 1 | 2013 | 246 | 0.020 |
Why?
|
| Cardiology | 1 | 2012 | 140 | 0.020 |
Why?
|
| Hemoptysis | 1 | 2010 | 28 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 3259 | 0.020 |
Why?
|
| Medication Adherence | 1 | 2013 | 335 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 742 | 0.020 |
Why?
|
| Dyspnea | 1 | 2010 | 87 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 506 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 867 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 373 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2012 | 483 | 0.020 |
Why?
|
| Patient Selection | 1 | 2013 | 592 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1619 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 880 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 1040 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 780 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 948 | 0.020 |
Why?
|
| Age Factors | 1 | 2013 | 1864 | 0.020 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 1420 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2012 | 657 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 8912 | 0.020 |
Why?
|
| South Carolina | 1 | 2012 | 2752 | 0.020 |
Why?
|